Italia markets closed

ILMN May 2024 125.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,9000-4,0000 (-81,63%)
In data: 03:59PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,9000
Aperto3,6500
Denaro0,7000
Lettera1,1500
Prezzo d'esercizio125,00
Scadenza2024-05-10
Min-Max giorno0,9000 - 3,6500
Contratto - Min-MaxN/D
Volume37
Open Interest60
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera